Eads & Heald Wealth Management Becton Dickinson & CO Transaction History

Eads & Heald Wealth Management

$197 Million
Q1 2025

A detailed history of Eads & Heald Wealth Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Eads & Heald Wealth Management holds 4,704 shares of BDX stock, worth $811,863. This represents 0.55% of its overall portfolio holdings.

Number of Shares

4,704

Previous 4,916 4.31%

Holding current value

$811,863

Previous $1.12 Million 3.41%

% of portfolio

0.55%

Previous 0.55%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$222.79 - $249.08 $47,231 - $52,804	-212 Reduced 4.31%	4,704 $1.08 Million
Q4 2024 Jan 17, 2025	SELL	$220.02 - $243.75 $130,911 - $145,031	-595 Reduced 10.8%	4,916 $1.12 Million
Q3 2024 Oct 28, 2024	SELL	$221.47 - $242.41 $79,950 - $87,510	-361 Reduced 6.15%	5,511 $1.33 Million
Q2 2024 Jul 23, 2024	SELL	$225.07 - $246.17 $156,198 - $170,841	-694 Reduced 10.57%	5,872 $1.37 Million
Q1 2024 Apr 23, 2024	SELL	$233.45 - $247.73 $252,359 - $267,796	-1,081 Reduced 14.14%	6,566 $1.63 Million
Q4 2023 Jan 30, 2024	SELL	$232.24 - $267.23 $22,062 - $25,386	-95 Reduced 1.23%	7,647 $1.87 Million
Q3 2023 Oct 27, 2023	SELL	$254.9 - $283.59 $102,979 - $114,570	-404 Reduced 4.96%	7,742 $2 Million
Q2 2023 Jul 25, 2023	SELL	$238.39 - $265.32 $199,770 - $222,338	-838 Reduced 9.33%	8,146 $2.15 Million
Q1 2023 Apr 21, 2023	SELL	$229.71 - $259.35 $40,658 - $45,904	-177 Reduced 1.93%	8,984 $2.22 Million
Q4 2022 Jan 27, 2023	BUY	$218.29 - $256.91 $21,174 - $24,920	97 Added 1.07%	9,161 $2.33 Million
Q3 2022 Oct 27, 2022	BUY	$51.03 - $264.23 $8,317 - $43,069	163 Added 1.83%	9,064 $2.02 Million
Q2 2022 Jul 26, 2022	BUY	$234.74 - $275.42 $39,201 - $45,995	167 Added 1.91%	8,901 $2.19 Million
Q1 2022 Apr 27, 2022	SELL	$243.64 - $270.48 $22,171 - $24,613	-91 Reduced 1.03%	8,734 $2.27 Million
Q4 2021 Jan 31, 2022	BUY	$230.08 - $250.94 $34,972 - $38,142	152 Added 1.75%	8,825 $2.17 Million
Q3 2021 Oct 27, 2021	BUY	$232.72 - $256.47 $17,919 - $19,748	77 Added 0.9%	8,673 $2.08 Million
Q2 2021 Jul 30, 2021	BUY	$232.65 - $254.58 $17,914 - $19,602	77 Added 0.9%	8,596 $2.04 Million
Q1 2021 Apr 29, 2021	BUY	$232.09 - $256.88 $12,997 - $14,385	56 Added 0.66%	8,519 $2.02 Million
Q4 2020 Feb 02, 2021	BUY	$221.92 - $245.94 $24,189 - $26,807	109 Added 1.3%	8,463 $2.07 Million
Q3 2020 Nov 02, 2020	SELL	$215.77 - $276.76 $127,951 - $164,118	-593 Reduced 6.63%	8,354 $1.9 Million
Q2 2020 Jul 29, 2020	SELL	$219.9 - $263.41 $58,713 - $70,330	-267 Reduced 2.9%	8,947 $2.09 Million
Q1 2020 May 01, 2020	SELL	$195.69 - $279.01 $60,272 - $85,935	-308 Reduced 3.23%	9,214 $2.07 Million
Q4 2019 Jan 31, 2020	BUY	$236.45 - $266.82 $5,911 - $6,670	25 Added 0.26%	9,522 $2.53 Million
Q3 2019 Oct 31, 2019	SELL	$230.58 - $256.08 $40,120 - $44,557	-174 Reduced 1.8%	9,497 $2.34 Million
Q2 2019 Jul 30, 2019	SELL	$217.4 - $246.08 $35,218 - $39,864	-162 Reduced 1.65%	9,671 $0
Q1 2019 Apr 26, 2019	BUY	$206.05 - $248.17 $26,786 - $32,262	130 Added 1.34%	9,833 $0
Q4 2018 Jan 31, 2019	SELL	$204.73 - $257.93 $40,536 - $51,070	-198 Reduced 2.0%	9,703 $2.13 Million
Q3 2018 Oct 31, 2018	SELL	$233.07 - $256.0 $71,785 - $78,848	-308 Reduced 3.02%	9,901 $0
Q2 2018 Jul 27, 2018	SELL	$208.1 - $233.85 $11,237 - $12,627	-54 Reduced 0.53%	10,209 $0
Q1 2018 Apr 26, 2018	BUY	$205.46 - $240.27 $58,556 - $68,476	285 Added 2.86%	10,263 $0
Q4 2017 Jan 31, 2018	BUY	$189.0 - $222.64 $304,101 - $358,227	1,609 Added 19.23%	9,978 $0
Q3 2017 Oct 27, 2017	BUY	$186.89 - $198.9 $1.56 Million - $1.66 Million	8,369	8,369 $0

Others Institutions Holding BDX

# of Institutions

1,806

Shares Held

257M

Call Options Held

3.24M

Put Options Held

841K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $49.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Account

Eads & Heald Wealth Management Becton Dickinson & CO Transaction History